Kim Giffoni, EVP Foreign Sales/Inv. Rel, 10% Owner at Targeted Medical Pharma, Inc. (TRGM), bought 4,800 shares at $1.09 ($5K) on 2013-11-29, disclosed to the SEC on 2013-12-04.
Open-market purchase of $5k TRGM by EVP Foreign Sales/Inv. Rel, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.06 | 2,500 | $3K | 52.1% |
| 2 | $1.09 | 600 | $654 | 12.9% |
| 3 | $1.05 | 1,700 | $2K | 35.1% |
| Total | $1.06 avg | 4,800 | $5K | 100% |
| Filing → |
| TRGM | BUY | 2013-12-11 | $11K | — | Filing → |